(Q46526456)

22 December 2017

title

Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program (English)

1 reference

22 December 2017

author name string

Delia S West

1

1 reference

22 December 2017

T Elaine Prewitt

2

1 reference

22 December 2017

Zoran Bursac

3

1 reference

22 December 2017

Holly C Felix

4

1 reference

22 December 2017

publication date

10 April 2008

1 reference

22 December 2017

published in

Obesity

1 reference

22 December 2017

volume

16

1 reference

22 December 2017

page(s)

1413-1420

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Achieving weight and activity goals among diabetes prevention program lifestyle participants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Diabetes trends in the USA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Prevalence of overweight and obesity in the United States, 1999-2004

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Overweight and obesity: prevalence, consequences, and causes of a growing public health problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

NIDDK data repository: a central collection of clinical trial data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Effect of weight loss with lifestyle intervention on risk of diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Motivational interviewing improves weight loss in women with type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

A combined breast health/weight loss intervention for Black women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Weight management using a meal replacement strategy: meta and pooling analysis from six studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.224

31 March 2020

Identifiers

DOI

10.1038/OBY.2008.224

1 reference

22 December 2017

PubMed ID

18421273

1 reference

22 December 2017